Raymond M. Johnson, M.D., Ph.D.
Raymond M. Johnson M.D., Ph.D. is basic scientist and clinical investigator with a subspecialty interest in treating HIV patients with hepatitis virus coinfections. Dr. Johnson received his M.D. and Ph.D. from the University of Chicago Pritzker School of Medicine. He did his internship, residency and ID fellowship at Washington University in St. Louis, MO. Dr. Johnson was a participant in early efforts to address coinfections in HIV patients including Expert Perspectives: Strategies for the Manangement of HIV/HCV Coinfection in 2000. He is currently the onsite principal investigator for AIDS Clinical Trial Group A5178 (SLAM-C),investigating the role of maintenance interferon therapy in HCV coinfected patients, and co-investigator for a recently completed clinical trial investigating the role of pegylated interferon in HBV coinfected patients. He also was an investigator for a clinical trial investigating the use of pegylated interferon as a component of salvage HAART therapy for HIV treatment failures. Dr. Johnson runs the Coinfection Clinic at the Indiana University School of Medicine.